102 related articles for article (PubMed ID: 14522542)
1. COMET: a proposed mechanism of action to explain the results and concerns about dose.
Wikstrand J; Fagerberg B; Goldstein S; Kjekshus J; Wedel H
Lancet; 2003 Sep; 362(9389):1076-7; author reply 1077-8. PubMed ID: 14522542
[No Abstract] [Full Text] [Related]
2. COMET: a proposed mechanism of action to explain the results and concerns about dose.
Hjalmarson A; Waagstein F
Lancet; 2003 Sep; 362(9389):1077; author reply 1077-8. PubMed ID: 14522544
[No Abstract] [Full Text] [Related]
3. COMET: a proposed mechanism of action to explain the results and concerns about dose.
Coca SG; Buller GK
Lancet; 2003 Sep; 362(9389):1076; author reply 1077-8. PubMed ID: 14522541
[No Abstract] [Full Text] [Related]
4. Beta-blockers for heart failure: is slowing of heart rate essential?
Tendera M
Eur Heart J; 1999 Apr; 20(8):560-1. PubMed ID: 10337539
[No Abstract] [Full Text] [Related]
5. [A randomized comparison of carvedilol and metoprolol in patients with chronic heart failure. The Carvedilol Or Metoprolol European Trial (COMET) ].
Torp-Pedersen CT;
Ugeskr Laeger; 2004 Aug; 166(32):2671-4. PubMed ID: 15347171
[No Abstract] [Full Text] [Related]
6. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
Di Lenarda A; Remme WJ; Charlesworth A; Cleland JG; Lutiger B; Metra M; Komajda M; Torp-Pedersen C; Scherhag A; Swedberg K; Poole-Wilson PA;
Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806
[TBL] [Abstract][Full Text] [Related]
7. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.
Zebrack JS; Munger M; Macgregor J; Lombardi WL; Stoddard GP; Gilbert EM
Pharmacotherapy; 2009 Aug; 29(8):883-90. PubMed ID: 19637941
[TBL] [Abstract][Full Text] [Related]
8. [The COMET study compares effect of two different beta-blockers in chronic heart failure. Carvedilol better than metoprolol].
Swedberg K
Lakartidningen; 2003 Sep; 100(37):2852-4. PubMed ID: 14558169
[No Abstract] [Full Text] [Related]
9. [COMET: metoprolol].
Handa S
Nihon Rinsho; 2007 Apr; 65 Suppl 4():521-5. PubMed ID: 17511103
[No Abstract] [Full Text] [Related]
10. Which beta-blocker for heart failure?
Patel MR; Gattis W
Am Heart J; 2004 Feb; 147(2):238. PubMed ID: 14760319
[No Abstract] [Full Text] [Related]
11. Commentary on the Carvedilol or Metoprolol European Trial (COMET).
Poole-Wilson PA
Am J Cardiol; 2004 May; 93(9A):40B-2B. PubMed ID: 15144936
[TBL] [Abstract][Full Text] [Related]
12. [A fairer comparison between carvedilol and metoprolol is still to be done].
Johnsson G; Aberg J
Lakartidningen; 2003 Oct; 100(44):3543-4, 3544-5. PubMed ID: 14651018
[No Abstract] [Full Text] [Related]
13. Metoprolol (Lopressor).
Med Lett Drugs Ther; 1978 Nov; 20(22):97-8. PubMed ID: 30035
[No Abstract] [Full Text] [Related]
14. Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial.
Kveiborg B; Major-Petersen A; Christiansen B; Torp-Pedersen C
Vasc Health Risk Manag; 2007; 3(1):31-7. PubMed ID: 17583173
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.
Deedwania PC; Giles TD; Klibaner M; Ghali JK; Herlitz J; Hildebrandt P; Kjekshus J; Spinar J; Vitovec J; Stanbrook H; Wikstrand J;
Am Heart J; 2005 Jan; 149(1):159-67. PubMed ID: 15660048
[TBL] [Abstract][Full Text] [Related]
16. 3-year follow-up of patients randomised in the metoprolol in dilated cardiomyopathy trial. The Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group.
Lancet; 1998 Apr; 351(9110):1180-1. PubMed ID: 9643698
[No Abstract] [Full Text] [Related]
17. [Controlled release metoprolol succinate in MERIT-HF. Analysis of patients subgroups].
Sidorenko BA; Bugrimova MA; Iosava IK; Pataraia SA; Preobrazhenskiĭ DV
Kardiologiia; 2008; 48(3):85-8. PubMed ID: 18429761
[TBL] [Abstract][Full Text] [Related]
18. Beta-blockers and heart failure.
Health News; 2000 Apr; 6(4):8. PubMed ID: 15356892
[No Abstract] [Full Text] [Related]
19. [Comet or snoop?].
Heinzl S
Med Monatsschr Pharm; 2003 Sep; 26(9):299. PubMed ID: 14526612
[No Abstract] [Full Text] [Related]
20. What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).
Gullestad L; Wikstrand J; Deedwania P; Hjalmarson A; Egstrup K; Elkayam U; Gottlieb S; Rashkow A; Wedel H; Bermann G; Kjekshus J;
J Am Coll Cardiol; 2005 Jan; 45(2):252-9. PubMed ID: 15653024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
